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Abstract 
 
 Under intracellular environment, proteins experience 
macromolecular crowding effects including specific/nonspecific 
interactions with other factors, which tunes their physical properties, e.g. 
3D structure, dynamics and conformational stability, and thus biological 
functions [1]. In situ observation of protein behaviours is therefore 
necessary. In-cell NMR [2] is currently the only approach that can provide 
structural information of proteins inside cells at atomic resolution. 
 Protein structure determination by in-cell NMR spectroscopy has 
been achieved in our laboratory for the first time using E. coli cells [3][4]. 
Extending in-cell NMR to study proteins inside eukaryotic cells has been 
another issue to be investigated, and was successfully tested recently for 
insect cells like sf9 [5]. In this study I employed human cultured HeLa cells 
as the host cells for in-cell NMR studies, since I believe that the knowledge 
obtained by in-"human"-cell NMR can be directly utilised in the advanced 
medical sciences and the pharmaceutical applications. 
 I selected human calbindin D9k(P47M+C80) as the model system. 
For in-"HeLa"-cell NMR experiments, we employed the protocols by 
Inomata et al.[6]: proteins of interest are overexpressed/labelled in E. coli, 
purified, and efficiently delivered to HeLa cells by linking the proteins with 
a cell-penetrating peptide (CPP-TAT from HIV-1) covalently. Inside the 
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HeLa cells the proteins are separated from the CPP-TAT by either 
endogeneous enzymatic activities or autonomous reductive cleavage. The 
expression system of calbindin D9k(P47M+C80), which has C-terminal Cys 
residue for CPP-TAT linking, was prepared. 15N- and 13C/15N-labelled 
proteins were purified for in-cell NMR experiments. Since a drastic 
reduction of the experimental time is necessary because of the low 
abundance of target proteins and short lifetime of the live cell samples, all 
the in-cell NMR experiments were measured with a nonlinear sampling 
scheme in the indirect dimension. SOFAST-type pulse techniques were 
used for extra reduction of the experimental time. All the NMR 
measurements were performed on a Bruker AVANCE-III 600 spectrometer 
equipped with a cryogenic probehead. 
 
1H-15N correlation cross peaks due to calbindin D9k(P47M+C80) in 
HeLa cells were well-resolved, suggesting that the proteins in HeLa cells 
are properly folded. However, when looking at four conjugative in-cell 2D 
1H-15N SOFAST-HMQC experiments (each took 38 mins), some spectral 
changes - peak disappearance and peak arising over measurements - were 
noticed. In order to investigate these spectral changes, cross peaks in each 
in-cell NMR spectrum were analysed by comparing with in vitro 
assignments of calbindin D9k(P47M+C80) in the metal-free (apo), Mg2+- 
and Ca2+-bound states, which were performed separately. As a result, 
calbindin D9k(P47M+C80) is in the Mg2+-bound state immediately after the 
start of NMR experiments, and gradually changed to the Ca2+-bound state, 
which leads to conformational changes in HeLa cells. In addition, it was 
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found that this spectral change did not depend on the initial metal-binding 
state of the CPP-TAT linked proteins, suggesting that the bound metal ions 
are released during the incorporation process into cells. Incorporated 
calbindin D9k(P47M+C80) binds Mg2+, since Mg2+ is abundant in cells, 
while Ca2+ is controlled at low (~µM) level. Next I introduced extra 
incubation time (~3 hrs) on culture dish prior to harvesting the cells for the 
experiments. Essentially identical results suggested that the spectral 
changes are initiated after the preparation of NMR samples. It is well 
known that HeLa cells release Ca2+ ions under various stresses, and heating 
caused by NMR radio frequency pulses was thought to be a source. 
Pre-incubation (~2hr) in NMR tubes inside the magnetic field showed that 
calbindin D9k(P47M+C80) is in the Ca2+-bound state, suggesting that not 
only the heating by RF pulses but also other stresses caused by the packing 
the cells into NMR tubes, e.g. cell precipitation due to gravity and oxygen 
starvation, stimulate the release of Ca2+ in cells. These stresses presumably 
release Ca2+ gradually, which are immediately captured by calbindin 
D9k(P47M+C80), since its affinity to Ca2+ is approximately 103 times 
higher than Mg2+. These results showed that HeLa cells are somehow 
suffering from various stresses during the in-cell NMR measurements, even 
though they are alive (the cell viability after 2.5 hrs' NMR experiments is 
more than 90 %). Further improvements in hardware, e.g. recycling the 
media so as to provide oxygen and nutrients continuously, would be 
preferable in order to achieve in situ measurements under more 
physiological condition in future. 
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Chapter 1 
 
 
Macromolecular crowding inside living 
cells 
 
 
 Intracellular conditions of the living cells are highly crowded by 
their cytoplasmic macromolecules like proteins, nucleic acids, etc. as well 
as many organelles like mitochondria, endoplasmic reticulum, golgi 
complex etc. [1]. Such condition is termed as “crowded” rather than 
“concentrated”, as no single macromolecular species exist at high 
concentration, but together. These macromolecules occupy a significant 
fraction of the total volume of the cytoplasmic space. Biological 
macromolecules have evolved to function inside such crowded 
environments. The crowding effects can make molecules in cells behave in 
different ways than in test-tube assays. Consequently, measurements of the 
properties of biological macromolecules or processes in biological 
activities that are made in the laboratory in dilute solutions (in vitro) may 
be different by many orders of magnitude from the true values seen in 
living cells (in vivo). Studies of biochemical processes under realistically 
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crowded conditions are very important, since the intracellular conditions 
are a ubiquitous property of all cells and crowding may be essential for the 
efficient operation of biological phenomena. 
 The total concentration of proteins and RNAs inside a cell of 
Escherichia coli is in the range of 300–400 g l−1 [1]. In eukaryotes, the 
interior of the cells is further crowded by the protein filaments that make up 
the cytoskeleton, this meshwork divide the cytosol into a network of 
narrow pores. Fig. 1.1 shows an artistic view of the interior of a eukaryotic 
cell. 
 As was mentioned above, these highly crowded macromolecules 
occupy a large proportion of the volume of the cells, which reduces the 
volume of solvent that is available for other macromolecules. This effect, 
defined as "excluded volume effect" [2], has been thought to select the most 
compact native structures of proteins. Experiments using organic polymers 
etc. as "crowders" support this theory [3-6]. On the other hand, various 
non-specific interactions are thought to select rather extended 
conformations with wider surface area.  Therefore, the protein structures 
and dynamics at intracellular environment exist under a fine balance of 
these effects (Fig.1.2). 
 Since it is difficult to mimic the intracellular environment in vitro, 
in situ observations become very important.  For an example, protein 
aggregation, binding to substrates and metal upon signalling are the 
consequences of crowding effects which can’t be studied in in vitro. 
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Fig.1.1 
An artistic view of macromolecular crowding inside the cell. This figure 
was downloaded from 
http://en.wikipedia.org/wiki/Macromolecular_crowding 
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Fig. 1.2 
  A schematic drawing of the various intracellular effects which may 
perturb protein structure and dynamics.  The changes in structure and 
dynamics of water surrounding proteins was proposed recently by 
molecular dynamics simulations [7]. 
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Chapter 2  
 
 
Methods to study of biomolecules inside 
living cells 
 
 
 Direct visualization of biomolecules like DNA, RNA, proteins and 
their structures and biological functions, became a necessary to understand 
cellular phenomena. Hence analytical techniques were developed to 
visualize and interpret them. A number of techniques are discussed below. 
 
 
2.1 Cryo- electron microscope 
 
 Cryo-electron microscope (cryo-EM) has been used as a standard 
technique to study biomolecules in in vitro and in vivo. Owing to the high 
magnification that can be achieved, transmission electron microscope 
(TEM) has helped uncovering the fine architecture of intracellular 
components and improved our understanding of the physiological process 
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of cells, in a number of different systems ranging from bacteriophages to 
mammalian cells [8]. Electron microscope can bridge the gap between 
ultra-structural compartmentalization and the structural analysis of 
molecular inhabitants of the cells, at a nanometer-length scale by providing 
high resolution 3D images (tomograms) of cellular landscapes. The 
combination of electron microscope with cryo-techniques, termed 
cryo-electron tomography (cryo-ET), enables the visualization of frozen 
hydrated biological samples unadulterated by harmful preparation methods. 
Some of the disadvantages are that it is necessary to keep the cells in 
vacuum and frizzed, and to construct unadulterated samples by harmful 
preparation methods, which are exactly not physiological conditions [9].   
 
 
2.2 Fluorescence resonance energy transfer microscopy 
 
 When light microscopy initiated our understanding of cellular 
structure and the associated function, molecular biological studies over the 
past few decades have shown that cellular events, such as signal 
transduction and gene transcription, require the assembly of proteins into 
specific macromolecular complexes. Traditional biophysical or 
biochemical methods did not provide direct access to the interactions of 
these protein partners in their natural environment. Intensity-based imaging 
techniques applying the method of fluorescence resonance energy transfer 
(FRET) microscopy was subsequently developed, facilitating the study of 
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these interactions inside intact living cells [10]. New imaging technologies, 
coupled with the development of new genetically encoded fluorescent 
labels and sensors and the increasing capability of computer software for 
image acquisition and analysis, have enabled more sophisticated studies of 
protein functions and processes ranging from gene expression to 
second-messenger cascades and intercellular signalling [11]. 
 Fluorescence resonance energy transfer (FRET) is a distance 
dependent physical process by which energy is transferred non-radiatively 
from an excited molecular fluorophore (the donor) to another fluorophore 
(the acceptor) by means of intermolecular long-range dipole–dipole 
coupling. FRET can be an accurate measurement of molecular proximity at 
angstrom distances (10–100 Å) and highly efficient if the donor and 
acceptor are positioned within the Förster radius (the distance at which half 
the excitation energy of the donor is transferred to the acceptor, typically 
3–6 nm). The efficiency of FRET is dependent on the inverse sixth power 
of intermolecular separation, making it a sensitive technique for 
investigating a variety of biological phenomena that produce changes in 
molecular proximity.  An example, capturing Ca2+ signaling in specific 
cellular compartments like the cytoplasm, nucleus, or endoplasmic 
reticulum can be observed by measuring the change in the ratio of the 
fluorescence intensities of acceptor and donor molecules in live cells [12]. 
Cameleons, a class of fluorescent indicators for Ca2+ based on GFPs and 
calmodulin (CAM), are useful tools in measuring the free Ca2+ 
concentrations in living cells.   
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 A disadvantage is, a fluorescence protein as a probe which must be 
fused to the target protein is needed for FRET based imaging technique.  
 
 
2.3 In-Cell NMR Spectroscopy 
 
 Since its discovery in 1945 the nuclear magnetic resonance (NMR) 
effect has developed from an interesting physical and chemical 
phenomenon into the most important analytical technique in chemistry, 
biology and medicine. Although, originally, NMR seemed to be too 
insensitive for applications to biological systems, many different 
techniques based on the NMR phenomenon have emerged during the last 
30 years. Today NMR spectroscopy is used for investigations of structure 
and dynamics of macromolecules as well as binding studies. One aspect 
that distinguishes NMR from other biophysical techniques is that it can be 
applied not only to purified in vitro samples of targeted macromolecule but 
also to investigations of living cells as well as entire organisms. In 
particular, imaging techniques have had and continue to have an enormous 
impact as a tool in medicine. Imaging techniques use differences in the 
properties of protons between different tissues to create images. 
Characteristics that can be used include differences in the T1 relaxation 
rates, or in the rate of diffusion. In addition to protons other nuclei have 
also been used for imaging purposes, for example 13C, 10B, and 11B. While 
imaging techniques provide information about entire organs, NMR can also 
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be used to obtain detailed information about molecular processes in living 
cells and organisms. In vivo NMR spectroscopy has for example been used 
to investigate metabolic fluxes [13-15]. In these experiments small 
molecules which are labelled with NMR active isotopes, for example 13C, 
are added to cells. Through the cellular metabolism these NMR active spins 
get incorporated into other molecules, which can be identified based on 
their characteristic chemical shifts. 
 The investigations of molecules in living cellular systems were 
limited to these classical in vivo (and metabolomics) NMR experiments 
that focus on small molecules. The gap between in vivo NMR experiments 
with small metabolic molecules together with imaging techniques 
providing information about entire organs and organisms and the behaviour 
of biological macromolecules inside living cells, bridged by in-cell NMR 
spectroscopy allowed investigator to understand cellular functions [16]. 
The observation of biological macromolecules in cellular systems is based 
on labelling schemes that enable the selective identification of these 
macromolecules in an environment that is crowded with other 
macromolecules as well as with many different small molecules. Basically 
two different approaches to achieve this goal exist. The first is 
overexpression of isotopically labelled protein inside host cells (E.coli [17], 
yeast [18], Mammalian [19]), and the second is either injecting the 
isotopically labelled proteins to the host cells in micro level (Xenopus 
Oocyte [20,21]) or incorporation by cell penetrating peptides [22] or 
pore-forming toxins [23]. These in-cell NMR methods have opened the 
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way to understand the in situ cellular functions and behaviours by looking 
at atomic level.  
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Chapter 3 
 
 
In-cell NMR Spectroscopy 
 
 
3.1 High resolution multi-dimensional NMR in living 
cells 
 
 On 2001, Serber et.al. established a novel biomolecular NMR 
technique, so-called “In-cell NMR”, to study protein behaviour at atomic 
resolution inside living E. coli cells [17]. They also proposed potential 
applications of this approach for investigating various biological events 
[16] (Fig.3.2.1). It is one of experimental methodologies to study biological 
macromolecules, such as proteins and DNAs, taking advantage of 
non-invasive property and atomic resolution of NMR spectroscopy, and 
uses living cells as NMR sample, in which 15N or 13C/15N labelled target 
macromolecules were incorporated. Since NMR signals of target molecules 
were directly observed from inside of the cells, behaviour of 
macromolecules in living cells are feasible to study with this technique. 
Over the past decade, this method has gradually being developed and 
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mainly used for analysing the protein behaviours in living prokaryotic and 
eukaryotic cells [24-26]. 
 
 
3. 2  In-cell NMR using prokaryotic cells. 
 
 All of reported in-cell NMR using prokaryotic cells employed E. 
coli cells as “host cell” [25]. E. coli cells which were used as in-cell NMR 
sample overexpressed recombinant target proteins and were labelled with 
NMR active isotope (Fig.3.2.2). In-cell NMR was first applied to proteins 
inside E. coli cells [17,27].  This method has been used to detect various 
intracellular behaviours of proteins such as conformational changes [28], 
dynamics [29], protein-protein [30] and protein-ligand [31] interactions and 
high resolution 3D structure [32,33] in living bacterial cells. Recently, 
bacterial in-cell NMR has been often used for investigating 
macromolecular crowding effect and new insights about protein dynamics 
[29], structural stability [34] and diffusion behaviours [35] in the crowded 
environment were reported. 
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Figure 3.2.1 
  Potential applications of in-cell NMR to investigate various biological 
events inside cells. 
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Figure 3.2.2 
  Schematic illustration of the in-cell NMR experiment in bacteria cells. 
 
 
3. 3  In-cell NMR using eukaryotic cells. 
 
3.3.1 Eukaryotic cells (non mammalian) 
 
In eukaryotic cells, in-cell NMR studies were first performed by 
injecting 15N-labelled proteins into Xenopus laevis oocytes or eggs [20,21]. 
Bertrand et al. reported the observation of in-cell NMR spectra of ubiquitin 
using the protein expression system in Pichia pastoris which provide us 
new insights for properties of Yeast intracellular vesicles [18]. Fig, 3.3.1.1 
shows the schematic representation of these approaches. 
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Fig.3.3.1.1 
  Illustrations of two different kind of sample preparations for in-cell 
NMR experiments, microinjection of target protein in Xenopus Oocyte 
[20,21] and overexpression of target protein in Yeast (Pichia pastoris)[8].   
 
 
3.3.2 Eukaryotic cells (mammalian) 
  
For cultured mammalian cells, cell-penetrating peptides [22] or the 
pore-forming toxin streptolysine O (SLO) [23] have been used to deliver 
proteins. These approaches achieved in situ observations of the 
post-translational modification [23,36] in eukaryotic cells. In addition, 
applications for pharmaceutical purposes are also anticipated [37] because 
of the ability of drug screening within living cells. Comparing to the 
protocols for bacterial in-cell NMR experiments, in which proteins of 
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interest are overexpressed in host cells, these protocols for eukaryotic cells 
have the big advantage that the resulting spectra are background free. The 
existing protocols for introducing stable isotope-labelled proteins into 
eukaryotic cells however require relatively large quantity of purified and 
concentrated stable-isotope enriched proteins, thus restricting the 
applications to proteins which are difficult to purify and/or unstable. The 
alternative approaches for eukaryotic in-cell NMR utilising the intrinsic 
protein expression system of host cells have therefore been awaited in order 
to extending the range of applications.  Banci et al. reported about the 
protein maturation in human cells where proteins were expressed in human 
cells [19]. Fig.3.3.2.1 shows a schematic representation of these methods 
described above. 
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Fig 3.3.2.1 
  Sample preparations for the culture mammalian cells (a) cell penetrating 
peptide CPPTAT [22], (b) Pore-forming toxin, Streptolysin O (SLO) [23], (c) 
Overexpression of target protein [19]  
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Chapter 4 
 
 
Aim of the Thesis 
 
 
 In this thesis, I focused on in-cell NMR study of human calbindin 
D9k inside the cultured human cells (HeLa cells). The aim of the thesis is to 
extend the in-cell NMR spectroscopic study to proteins in eukaryotic cells, 
exclusively on HeLa cells. In addition, I have used human calbindin D9k as 
a target protein to understand its behaviour inside the HeLa cells and Ca2+ 
binding process inside the HeLa cells during the in-cell NMR 
measurements. 
 Calcium ion (Ca2+) is the most common signal transduction in 
living cells, from single cell bacteria to highly developed human cells 
[38-40]. Many cellular proteins bind Ca2+ tightly, in some cases simply to 
buffer or lower free Ca2+ and some trigger second-messenger pathway. 
Normal intracellular Ca2+ level is kept at lower concentration around ~100 
nM, since it precipitate phosphate and, thought Ca2+-dependent signal 
transduction pathways, Ca2+ controls a wide variety of cellular process such 
as cell-cycle progression, differentiation, muscle contraction, enzymatic 
activities and extracellularly, Ca2+ wave and cell morphology [41]. Excess 
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intracellular Ca2+ can result enzymatic breakdown of proteins and cell 
death by stress. Influx of Ca2+ upon stimulation either from intracellular 
stores or through different types of Ca2+ channel leads to an increase in 
intracellular Ca2+ concentration, which eventually triggers apoptosis 
[42,43]. To maintain low concentration, Ca2+ is actively pumped from the 
cytosol to the extracellular space and into the endoplasmic reticulum (ER), 
and sometimes in the mitochondria [44]. This allows Calcium binding 
proteins (CaBPs) to bind Ca2+, undergo a conformational change and 
associate with different target proteins, hence biological effects of the Ca2+ 
signals.  
 Calcium binding proteins are usually low molecular weight and 
acidic protein which are composed of two distinct EF hands flanked by 
hydrophobic regions at either terminus and separated by a central hinge 
region. It is believed that this Ca2+ binding process is of cooperative way 
[45]. In contrast to Ca2+, Mg2+ is also essential element with structural and 
catalytic activities, which is quite abundant divalent metal ion within cells 
(0.5-2.0 X10-3 M). In resting cell, the free Ca2+ concentration is 1000 fold 
less than free Mg2+, calcium binding proteins are of Mg2+ bound form. If 
the balance between Mg2+ and Ca2+ concentration inside cell is disturbed, a 
semi-stressed state is experienced. As Mg2+ is important for stress-response, 
low level Mg2+ concentration means, the stress response can’t subside as it 
would be. With the increase of Ca2+ inside cells due to stress or other 
biological activities, these CaBPs bind Ca2+ and release Mg2+. It is reported 
that prolonged stress force ER to release calcium and induce cell death and 
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aging related diseases [46].  This excess calcium should be absorbed by 
CaBPs in order to prevent from cell death or disorderedness.  
Inorder to understand these intracellular phenomena, we initiated 
in-cell NMR methodology, where human calbindin D9k(P47M+C80) was 
used as a probe molecule inside human (HeLa) cells (chapter-6) . For the 
reference and to check the quality of in-HeLa-cell spectra, in vitro NMR 
experiments were performed. (chapter-5). In vitro NMR experiments were 
performed on lysine selective labelled human calbindin D9k of its various 
form (metal free, Mg2+ and Ca2+ bound form) in order to reduce the 
ambiguity in interpreting the in-HeLa-cell spectra. Various modifications of 
the in-Hela-cell sample preparations were carried out to confirm the 
cellular stress and understanding the intracellular phenomena during the 
in-Hela-cell NMR experiments (chapter-7). I believe that our result can be 
used as a reference for understanding the cellular stress and its related intra 
cellular phenomena by in-cell NMR spectroscopy. Healthiness of the cells 
during the in-cell NMR measurement is also important information can be 
obtained easily by our experimental procedure.  
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Chapter 5 
 
 
In vitro NMR spectroscopy 
 
 
5.1 Model System 
 
 Human calbindin D9k is a small (79 residue) Ca2+ binding protein of 
low molecular weight (9 K), highly expressed in cytoplasm of mammalian 
intestinal epithelial cells [41]. It can also be found in the kidney and uterus 
in some mammalian species [47]. This protein is a member of the S100 
superfamily of calcium binding proteins. It has two EF-hands sequences 
which bind Ca2+ with high affinity [48]. Calbindin D9k acts like a buffer 
protein to control the Ca2+ concentration [49] and has less interaction 
partner in cytoplasm, makes it as a suitable candidate for our study. 
 
 
5.2 Sample preparation for in vitro NMR spectroscopy 
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5.2.1 Expression 
 
 The DNA fragment encoding the human calbindin D9k gene 
containing the proline 47 to methionine (P47M) mutation and the 
C-terminal additional cysteine residue for the CPPTAT conjugation 
[henceforth referred as calbindin D9k(P47M+C80)] was synthesised. The 
P47M mutation was introduced so as to restrict cis-trans isomerisation [50]. 
The DNA fragment was inserted into a pET3a vector for overexpression in 
the E.coli BL21 Star (DE3) pLysS strain (Invitrogen). Uniformly 
13C/15N-labelled samples were prepared by growing the transformed 
bacteria in M9 minimal medium containing 15NH4Cl and [13C6]-D-glucose 
as the sole sources of nitrogen and carbon, respectively. For the preparation 
of uniformly 15N-labelled samples, [13C6]-D-glucose was replaced by the 
same concentration of unlabelled D-glucose. The lysine-selectively 
15N-labelled samples were prepared by using M9 minimal medium 
containing 100 mg/L 15N-lysine. Cells were grown at 37 °C, and protein 
expression was induced by the addition of isopropyl 
thio-β-D-thiogalactoside. After ~14 hours of further growth, the cells were 
harvested. 
 
5.2.2 Purification of human calbindin D9k(P47M+C80) 
 
 All the following steps in the purification protocol were carried out 
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at 4 °C unless mentioned. Re-suspending in the lysis buffer [20 mM 
imidazole (pH 7.0), 20 mM NaCl and 1 mM EDTA], the harvested cells 
were lysed by sonication. The cleared lysate was prepared by 
ultra-centrifugation, and then mixed with equal amount of the pre-heated 
(95 °C) lysis buffer, and kept at 95 °C for 3 minutes. After cooling down on 
ice, precipitated proteins were removed by another ultra-centrifugation. The 
supernatant was then loaded onto a DEAE-Sepharose (GE Healthcare) 
column pre-equilibrated with the lysis buffer. The column was washed with 
5 column volume of the same buffer, followed by elution with a linear 
gradient of 20-300 mM NaCl. The fractions containing calbindin 
D9k(P47M+C80) were loaded onto a Superdex-75 16/60 column (GE 
Healthcare) pre-equilibrated with the preparation buffer [20 mM Tris-HCl 
(pH 7.4), 20 mM NaCl , and 1 mM EDTA]. Further purification was 
carried out by Resource-Q (GE Healthcare) column chromatography with a 
linear gradient of 0-200 mM NaCl. 
 The purified calbindin D9k(P47M+C80), which was in the 
metal-free state, was concentrated (~1.5 mM) and dissolved in the NMR 
buffer [20 mM Tris-HCl (pH7.4), 150 mM NaCl, and 5 mM DTT]. For the 
preparation of samples in the Mg2+- and Ca2+-bound states, MgCl2 and 
CaCl2 solutions were added at the final concentration of 5 mM, respectively 
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5.3 Heteronuclear 3D NMR experiments 
 
High resolution multi-dimensional NMR [51,52] is widely used for the 
field of protein sciences because of its capability to observe accurate 
structural and dynamic information of proteins in atomic resolution. When 
focusing on protein structural studies, X-ray crystallography is more 
popular and powerful tool. One of notable advantages of protein NMR 
spectroscopy is, however, that it has ability to analyse high resolution 
protein structures and dynamics in a solution state. Since most of the 
proteins work in a solution state in living cells, NMR spectroscopy can 
only provide detailed information of protein behaviours under the condition 
close to the physiological one. 
In the last 30 years, solution state NMR techniques for studies of protein 
structures and dynamics have been drastically developed. It is well known 
that one of the major bottle-neck of the protein structure determination by 
NMR is the molecular size and therefore many methods in NMR 
spectroscopy were developed to analyse higher molecular weight proteins.  
Structural information of target molecules obtained by solution NMR 
contain  chemical shifts, scalar coupling constants, (residual) dipolar 
couplings, line shapes and intensity in NMR spectra. To link appropriate 
atoms of proteins with NMR derived information, chemical shift 
assignments are the most important task for protein analysis. Nowadays 
unambiguous assignments of backbone and side-chain NMR-observable 
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atoms are performed by the combination of 3D/4D triple-resonance NMR 
[53] spectra which provide intra- and inter-residual connectivities of 
observed resonances.  
On the other hand, since tens of thousands of FIDs have to be measured, 
a considerable drawback of high dimensional (3D/4D) NMR experiments is 
that it is necessity to spend long measurement time (~ days for a set of 3D 
experiments/ ~ weeks for a set of 4D experiments). It implies that unstable 
proteins are not suitable for these experiments. To solve this problem, rapid 
multi-dimensional NMR measurement techniques such as Non-linear 
sampling [54,55], SOFAST [56,57], and Single-scan NMR [58], and so on, 
were developed. Drastic reduction of experimental time with high 
resolution spectra can be observed using these techniques. 
 
 
5.4 Non-linear sampling and Data Processing 
 
As was described in the previous section, one of the major 
draw-back of multidimensional NMR is a lot of experimental time needed 
for observing 3D/4D spectra. Total number of FIDs increased depending on 
the number of data points in indirect dimensions. Number of scans for each 
FID and the recycling delay time also increase the total measurement time. 
The non-linear sampling scheme [54] utilises the same pulse 
schemes of conventional multi-dimensional NMR experiments, but the 
FIDs are acquired in a non-linear fashion. Since the FIDs are acquired in 
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non-linear fashion, discrete Fourier transformation, which is widely used 
for NMR data processing, is not applicable for the indirect dimensions any 
more. To obtain analysable spectra from the non-linearly sample data, a 
variety of mathematical processing techniques such as Maximum Entropy 
(MaxEnt) [59,60],  Multi-Dimensional Decomposition (MDD) [61,62], 
Forward MaxEnt (FM) [63], Compressed Sensing (CS) [64,65], and 
quantitative Maximum Entropy (QME) [66] etc. have been reported. These 
techniques provide multi-dimensional spectra with much higher resolution 
from the data acquired with non-linearly sampling schemes when 
comparing to the data with the same number of FIDs, acquired with 
conventional sampling scheme. 
 
 
5.5 Heteronuclear NMR experiments for backbone 
resonance assignments 
 
5.5.1  2D 1H-15N HSQC. 
 
2D 1H-15N HSQC spectrum was recorded on 15N-labelled samples with 
8 transients. A total of 1024 (t2, 1HN) × 256 (t1, 15N) complex points were 
acquired for in vitro sample. 
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Fig. 5.5.1.1 
 Pulse sequence for the 2D 1H-15N HSQC experiment. Narrow 
filled-in and wide open bars represent 90° and 180° pulses, respectively. 
Short filled-in bars indicate ~1.4 ms 90° water flip-back pulses. Unless 
indicated, pulses are applied on the x axis. The G1, G2 and G3 gradient 
pulses are smoothed-square shaped and have durations of 2.3, 0.8 and 0.4 
ms, respectively. Their corresponding peak powers are 10, -10 and -50 
G/cm along the z-axis. Delay: δ = 2.3 ms. Phase cycling: ψ1 = x, -x; φ1 = 
4(x), 4(-x); φ2 = 2(x), 2(-x); Rec. = x, -x, -x, x. The phase sensitive 
detection in 15N dimension is achieved by incrementing phase ψ1 
according to States-TPPI scheme [67]. 
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   5.5.2  3D CBCA(CO)NH/CBCANH 
 
To observe inter- and intra-residual correlations and chemical shifts of 
13Cα and 13Cβ, 3D CBCA(CO)NH [68] and CBCANH [69] were measured. 
The 3D CBCA(CO)NH and CBCANH spectra were recorded on 
13C/15N-labelled samples with 8 transients and 512 complex points for the 
acquisition dimension (t3, 1HN). For indirect dimension, a total 264 of FIDs 
from 48 (t1, 13Cα/β) × 22 (t2, 15N) sampling space were randomly acquired. 
In both experiments, the WATERGATE block [70] was implemented before 
acquisition in the pulse sequences for solvent suppression. 
 
5.5.3  3D HNCO/HN(CA)CO 
 
To observe inter- and intra-residual correlation and chemical shifts of 
13C’, 3D HNCO [71] and HN(CA)CO [72] were also measured. The 3D 
HNCO and HN(CA)CO spectra were recorded on 13C/15N-labelled samples 
with 8 transients and 512 complex points for the acquisition dimension (t3, 
1HN). For indirect dimension, a total 352 of FIDs from 64 (t1, 13C’) × 22 (t2, 
15N) sampling space were randomly acquired. In both experiments, the 
WATERGATE block was implemented before acquisition in the pulse 
sequences for solvent suppression.  
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Fig.5.5.2.1 
 Pulse sequence for the 3D CBCA(CO)NH experiment. Narrow 
filled-in and wide open bars represent 90° and 180° pulses, respectively. 
Short filled-in bars indicate ~1.4 ms 90° water flip-back pulses. The 90° 
pulses flanking DIPSI-2 [73] decoupling intervals which are applied using 
a ~4.2 kHz field. 1H DIPSI-2 decoupling is achieved using a ~4.2 kHz field. 
Rectangle 90° pulses for 13Cα/β and 13C’ are applied using 5.1 and 4.7 kHz 
field, respectively. Filled-in shaped pulses marked with “ * ” have an Q374 
profile with duration 256 ms and 13Cα/β carrier is positioned at 40 ppm, 
while without “*” indicate have RSNOB [75] profile with 367 ms duration 
and applied at 52 ppm for 13Cα. Open shaped pulses have SEDUCE-1[76] 
profile with 192 ms and applied at 173 ppm. Unless indicated, pulses are 
applied on the x axis. The G1, G2, G3, G4, G5 and G6 gradient pulses are 
smoothed-square shaped and have durations of 0.4, 0.4, 0.8, 1.8, 2.3 and 
0.4 ms, respectively. Their corresponding peak powers are 20, 12, 10, 10, 
10 and 80 G/cm along the z-axis. Delays: δ1 = 1.5 ms, δ2 = 1.1 ms, δ3 = 3.8 
ms, δ4 = 4.4 ms, δ5 = 12.4 ms, δ6 = 5.4 ms, δ7 = 2.3 ms, TC = 3.1 ms, TN = 
12.0 ms. Phase cycling: ψ1 = 8(x), 8(-x); ψ2 = 4(x), 4(-x); φ1 = y, -y; φ2 = 
2(x), 2(-x); φ3 = 4(x), 4(-x); Rec. = x, 2(-x), x, -x, 2(x), -x, x, 2(-x), x. 
Phase sensitive detections in 13C and 15N dimension are achieved by 
incrementing phases ψ1 and ψ2 according to States-TPPI scheme. 
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Fig.5.5.2.2 
 Pulse sequence for the 3D CBCANH experiment. Narrow filled-in 
and wide open bars represent 90° and 180° pulses, respectively. Short 
filled-in bars indicate ~1.4 ms 90° water flip-back pulses. The 90° pulses 
flanking DIPSI-2 decoupling intervals which are applied using a ~4.2 kHz 
field. 1H DIPSI-2 decoupling is achieved using a ~4.2 kHz field. Rectangle 
90° pulse for 13Cα/β is applied using a 5.1 kHz field. Filled-in shaped pulses 
marked with “ * ” have a Q3 profile with duration 256 ms and 13Cα/β carrier 
is positioned at 40 ppm, while without “*” indicate have a RSNOB profile 
with 367 ms duration and applied at 52 ppm for 13Cα. Open shaped pulses 
have a SEDUCE-1 profile with 192 ms and applied at 173 ppm. Unless 
indicated, pulses are applied on the x axis. The G1, G2, G3, G4 and G5 
gradient pulses are smoothed-square shaped and have durations of 0.4, 0.4, 
1.8, 2.3 and 0.4 ms, respectively. Their corresponding peak powers are 20, 
12, 10, 10 and 80 G/cm along the z-axis. Delays: δ1 = 1.5 ms, δ2 = 1.1 ms, 
δ3 = 11.0 ms, δ4 = 5.3 ms, δ5 = 2.3 ms, TC = 3.1 ms, TN = 12.0 ms. Phase 
cycling: ψ1 = 8(x), 8(-x); ψ2 = 4(x), 4(-x); φ1 = y, -y; φ2 = 2(x), 2(-x); φ3 = 
4(x), 4(-x); Rec. = x, 2(-x), x, -x, 2(x), -x, x, 2(-x), x. Phase sensitive 
detections in 13C and 15N dimension are achieved by incrementing phases 
ψ1 and ψ2 according to States-TPPI scheme.  
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Fig.5.5.3.1 
 Pulse sequence for the 3D HNCO experiment. Narrow filled-in and 
wide open bars represent 90° and 180° pulses, respectively. Short filled-in 
bars indicate ~1.4 ms 90° water flip-back pulses. The 90° pulses flanking 
DIPSI-2 decoupling intervals which are applied using a ~4.2 kHz field. 
Rectangle 90° pulse for 13C’ is applied using a 4.7 kHz field. 1H DIPSI-2 
decoupling is achieved using a ~4.2 kHz field. Filled-in shaped pulses have 
RSNOB profile with 367 ms duration and applied at 52 ppm for 13Cα. Open 
shaped pulses have SEDUCE-1 profile with 192 ms and applied at 173 
ppm. Unless indicated, pulses are applied on the x axis. The G1, G2, G3, G4, 
G5 and G6 gradient pulses are smoothed-square shaped and have durations 
of 0.4, 2.3, 1.8, 1.3, 0.8 and 0.4 ms, respectively. Their corresponding peak 
powers are 5, 10, 10, 10, 10 and 50 G/cm along the z-axis. Delays: δ1 = 2.3 
ms, δ2 = 5.5 ms, TN = 12.0 ms. Phase cycling: ψ1 = 2(x), 2(-x); ψ2 = 4(x), 
4(-x); φ1 = y, -y; φ2 = 2(x), 2(-x); φ3 = 4(x), 4(-x); Rec. = x, -x, -x, x, -x, x, 
x, -x. Phase sensitive detections in 13C and 15N dimension are achieved by 
incrementing phases ψ1 and ψ2 according to States-TPPI scheme. 
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Fig. 5.5.3.2 
 Pulse sequence for the 3D HN(CA)CO experiment. Narrow filled-in 
and wide open bars represent 90° and 180° pulses, respectively. Short 
filled-in bars indicate ~1.4 ms 90° water flip-back pulses. The 90° pulses 
flanking DIPSI-2 decoupling intervals which are applied using a ~4.2 kHz 
field. Rectangle 90° pulses for 13Cα and 13C’ are applied using a 4.7 kHz 
field. 1H DIPSI-2 decoupling is achieved using a ~4.2 kHz field. Filled-in 
shaped pulses have RSNOB profile with 367 ms duration and applied at 52 
ppm for 13Cα. Open shaped pulses have SEDUCE-1 profile with 192 ms 
and applied at 173 ppm. Unless indicated, pulses are applied on the x axis. 
The G1, G2, G3, G4, G5, G6, G7 and G8 gradient pulses are smoothed-square 
shaped and have durations of 0.4, 2.3, 1.8, 1.5, 1.2, 1.0, 0.8 and 0.4 ms, 
respectively. Their corresponding peak powers are 5, 10, 10, 10, 10, 10, 10 
and 50 G/cm along the z-axis. Delays: δ1 = 2.3 ms, δ2 = 5.5 ms, δ3 = 3.8 ms, 
TN = 12.0 ms. Phase cycling: ψ1 = 4(x), 4(-x); ψ2 = 8(x), 8(-x); φ1 = y, -y; 
φ2 = 4(x), 4(-x); φ3 = 2(x), 2(-x); Rec. = x, 2(-x), x, -x, 2(x), -x, x, 2(-x), x. 
Phase sensitive detections in 13C and 15N dimension are achieved by 
incrementing phases ψ1 and ψ2 according to States-TPPI scheme. 
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5.6  Data processing and analysis 
 
For 2D NMR data, a 1D maximum entropy reconstruction was 
applied for the indirectly acquired 15N-dimension after processing the 
directly acquired dimension by Fourier transformation using Azara v2.8 (W. 
Boucher, www.bio.cam.ac.uk/azara).  For 3D NMR data, a 2D 
quantitative maximum entropy (QME) [66,77] reconstruction was applied 
for the indirectly acquired dimensions (t1 and t2) after processing the 
directly acquired dimension (t3) by Fourier transformation. 
QME provides improved results in comparison to the maximum 
entropy (MaxEnt) [59] reconstruction in the Azara v2.8 software. In 
particular, while one has to arbitrarily determine the Lagrange multipler, λ, 
in the original MaxEnt recon-struction, in the QME calculation one 
determines it by seeking the extremum of an approximated conditional 
probability distribution of the experimental data given λ. Hence, this 
achieves the optimal λ for an entire spectrum ameliorating some of the 
problems faced when reconstructing spectra such as those in which there is 
wide dynamic range, as is often the case in in-cell spectra. 
All NMR spectra were analysed using the CcpNmr Analysis 2.2.2 
software [78]. 
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Fig. 5.5.1 
 A schematic diagram showing the 2D QME processing protocol, by 
which an equivalent quality of the spectra can be obtained when non-linear 
sampling scheme is used in contrast to conventional sampling scheme for 
the reduction of NMR measurement time. 
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5.7  Backbone resonance assignments 
 
 The standard procedures for backbone resonance assignments of 
small to medium size proteins use 3D CBCANH and 3D CBCA(CO)NH 
spectra. 3D CBCANH correlates each NH group with Cα and Cβ chemical 
shift of its own residue (strongly, so peaks are appeared to be strong) and of 
the residue preceding (weakly, so weak peaks are also appeared). 3D 
CBCA(CO)NH only correlates the NH group to the preceding Cα and Cβ 
chemical shifts. Fig. 5.7.1 shows the strategy for backbone resonance 
assignment of proteins by analysing CBCA(CO)NH and CBCANH spectra. 
 Supplementing with 3D HN(CA)CO and 3D HNCO spectra, where 
HN(CA)CO correlates each NH(i) group with C’(i) and C’(i-1), while 
HNCO correlates each NH(i) group with C’(i-1) ( C’ referred to carbonyl 
carbon ). Combining all these four 3D triple-resonance spectra and 
following the assignment strategies, we have performed the backbone 
resonance assignments for the metal free (Fig 5.7.3), Mg2+ bound (Fig 
5.7.4) and Ca2+ bound (Fig.5.7.5) human calbindin D9k. (results are 
summarised in Table 5.7.1,  5.7.2, 5.7.3 respectively). Selected 1H-13C 
strips from the CBCA(CO)NH, CBCANH, HNCO and HN(CO)CA spectra 
measured on the calbindin D9k(P47M+C80) in the Ca2+-bound state are 
shown in Fig.5.7.2. 
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Fig 5.7.1 
 The strategy for backbone resonance assignment of proteins by 
analysing 3D CBCA(CO)NH and CBCANH spectra. 
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Fig 5.7.2 
 Selected 1HN-13C strips extracted from the 3D CBCA(CO)NH and 
CBCANH spectra (overlaid, upper panel) and the 3D HNCO and 
HN(CA)CO spectra (overlaid, lower panel) of calbindin D9k(P47M+C80) 
in the Ca2+-bound state. Each strip corresponds to the 15N frequency of the 
residue indicated. Sequential connectivities are represented by lines. 
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Fig 5.7.3 
 15N-HSQC showing the backbone resonance assignment of the 
metal free ( Apo) human calbindin D9k (P47M+C80). 
 
 
 
  
51 
 
Table 5.7.1 
 Backbone resonance assignment of the metal free human calbindin 
D9k(P47M+C80) in vitro at 37 °C. 
 
Residue 
No. Type 
1HN 15N 13C’ 13Cα 13Cβ 
1 Met - - - - - 
2 Ser - - - - - 
3 Thr - - - - - 
4 Lys - - - - - 
5 Lys 8.34 124.11 176.12 55.31 34.31 
6 Ser 8.84 121.92 173.1 56.79 63.28 
7 Pro - - 179.17 66.21 31.9 
8 Glu 8.55 118.98 179.12 60.17 29.14 
9 Glu 7.84 123.18 179.5 59.15 30.18 
10 Leu 8.54 120.81 178.83 58.4 42.06 
11 Lys 8.2 122.09 177.69 59.58 31.99 
12 Arg 7.58 119.97 179.88 59.43 30.42 
13 Ile 8.01 121.23 176.77 65.51 38.9 
14 Phe 8.5 121.81 176.96 62.87 40.14 
15 Glu 8.71 118.25 178.93 59.61 29.9 
16 Lys 7.55 120.52 177.92 59.08 32.29 
17 Tyr 7.27 117.66 178.15 60.81 39.77 
18 Ala 8.9 126.58 178.02 54.77 19.02 
19 Ala 7.13 116.13 178.79 53 19.03 
20 Lys 7.02 117.82 176.47 59.44 33.05 
21 Glu 7.59 116.68 174.98 55.01 32.76 
22 Gly 8.37 110.59 174.36 45.95 - 
23 Asp 8.69 129.12 176.71 52.16 41.86 
24 Pro - - 175.16 64.03 31.48 
25 Asp 8.5 118.34 175.51 53.48 41.99 
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Table 5.7.1 continued 
 
Residue 
No. Type 
1HN 15N 13C’ 13Cα 13Cβ 
26 Gln 7.6 119.32 173.35 54.46 33.57 
27 Leu 8.83 122.85 175.97 52.97 46.34 
28 Ser 8.63 122.29 175.13 57.61 65.12 
29 Lys 8.54 123.55 178.15 60.7 31.95 
30 Asp 8.22 118.79 179.21 57.63 40.56 
31 Glu 7.62 122.48 178.49 58.69 30.04 
32 Leu 8.48 122.95 177.97 57.9 41.07 
33 Lys 7.76 119.66 178.4 60.95 32.3 
34 Leu 7.06 120.7 178.86 58 41.34 
35 Leu 8.16 124.44 179.46 59.18 42.29 
36 Ile 8.47 121.79 177.4 65.33 37.17 
37 Gln 7.63 117.71 176.91 59.14 29.38 
38 Ala 7.89 119.65 180.12 54.26 20.2 
39 Glu 8.58 114.75 176.75 56.02 30.2 
40 Phe 8.13 118.75 173.45 55.01 40.03 
41 Pro - - - 65.41 31.21 
42 Ser 8.26 115.48 175.78 60.48 62.55 
43 Leu 7.92 123.21 177.45 55.83 41.75 
44 Leu 7.46 120.11 177.66 55.8 41.57 
45 Lys 7.77 121.54 177.19 57.29 32.47 
46 Gly 8.09 110.39 - 45.37 - 
47 Met - - - - - 
48 Asn - - 175.75 54.7 38.73 
49 Thr 7.81 114.06 175.34 62.55 70.06 
50 Leu 8.1 123.73 177.73 57.57 41.67 
51 Asp 8.02 119.81 178.63 57.88 40.42 
52 Asp 7.88 121.4 178.66 57.25 40.5 
  
53 
 
Table 5.7.1 continued 
 
Residue 
No. Type 
1HN 15N 13C’ 13Cα 13Cβ 
53 Leu 7.76 122.81 178.92 57.58 42.06 
54 Phe 8.39 119.67 177.65 60.44 38.29 
55 Gln 7.83 119.95 178.16 58.91 28.61 
56 Glu 7.66 120 177.93 58.4 29.75 
57 Leu 7.55 120.39 177.47 55.85 42.39 
58 Asp 8 120.91 177.1 55.02 40.27 
59 Lys 7.88 122.47 177.15 57.35 32.87 
60 Asn 8.2 118.95 176.01 53.35 39.08 
61 Gly 8.04 111.09 174.29 46.19 - 
62 Asp 8.3 122.25 176.96 54.24 41.34 
63 Gly 8.86 111.5 173.43 45.92 - 
64 Glu 7.98 121.21 175.52 55.5 32.25 
65 Val 9.01 118.36 175.21 60.67 34.86 
66 Ser 8.67 121.66 175.33 57.06 66.61 
67 Phe 9.32 124.32 177.26 61.42 38.4 
68 Glu 8.52 120.09 179.4 60.33 29.04 
69 Glu 7.35 120.63 178.8 59.08 30.25 
70 Phe 8.61 123.33 175.71 60.74 39.47 
71 Gln 8.03 118.79 178.12 59.93 29.42 
72 Val 7.05 120.97 177.96 66.51 31.73 
73 Leu 7.74 122.99 178.48 58.6 41.71 
74 Val 7.94 117.99 178.38 66.2 31.14 
75 Lys 7.43 122.91 178.73 59.63 32.01 
76 Lys 7.79 120.29 179.28 59.25 32.73 
77 Ile 7.88 116.31 176.52 63.46 38.16 
78 Ser 7.61 116.76 174.09 59.57 63.88 
79 Gln 7.64 122.24 174.97 56.09 28.96 
80 Cys 7.68 125.54 178.59 60.03 29.17 
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Fig 5.7.4 
 15N-HSQC showing the backbone resonance assignments of the 
Mg2+ bound human calbindin D9k (P47M+C80). 
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Table 5.7.2 
 Backbone resonance assignment of the Mg2+bound human calbindin 
D9k(P47M+C80) in vitro at 37°C 
 
Residue 
No. Type 
1HN 15N 13C’ 13Cα 13Cβ 
1 Met - - - - - 
2 Ser - - - - - 
3 Thr - - - - - 
4 Lys - - - - - 
5 Lys 8.29 123.83 176.3 55.17 34.33 
6 Ser 8.84 121.94 173.05 56.82 63.3 
7 Pro - - 179.12 66.18 31.92 
8 Glu 8.55 118.97 179.1 60.1 29.14 
9 Glu 7.83 123.16 179.42 59.09 30.19 
10 Leu 8.6 121.09 178.79 58.4 42.1 
11 Lys 8.2 122.07 177.67 59.55 31.97 
12 Arg 7.54 120.07 179.87 59.42 30.41 
13 Ile 7.98 121.22 176.81 65.52 38.82 
14 Phe 8.59 121.85 176.83 62.8 40.06 
15 Glu 8.7 118.28 178.91 59.59 29.91 
16 Lys 7.49 120.33 177.75 59.07 32.34 
17 Tyr 7.22 117.48 178.04 60.81 39.77 
18 Ala 8.98 126.33 178.23 54.74 19.17 
19 Ala 7.02 115.57 178.76 52.97 18.78 
20 Lys 7.02 117.94 176.46 59.52 33.02 
21 Glu 7.54 116.44 174.92 55.02 32.71 
22 Gly 8.35 110.63 173.99 45.94 - 
24 Pro - - - 64.08 31.48 
25 Asp 8.5 118.12 175.65 53.37 41.94 
26 Gln 7.58 120 173.24 - - 
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Table 5.7.2 continued 
 
Residue 
No. Type 
1HN 15N 13C’ 13Cα 13Cβ 
27 Leu - - - - - 
28 Ser 8.68 124.2 174.67 57.58 65.26 
29 Lys 7.63 122.79 177.72 60.78 31.49 
30 Asp 8.25 118.54 179.36 57.74 40.5 
31 Glu 7.47 121.92 178.39 58.68 29.91 
32 Leu 8.47 122.83 178.04 57.91 41.04 
33 Lys 7.87 119.85 178.56 61.12 32.21 
34 Leu 7.02 121 178.57 57.98 41.31 
35 Leu 8.08 124.7 179.46 59.22 42.27 
36 Ile 8.56 122.11 177.39 65.29 37.15 
37 Gln 7.59 117.69 176.83 59.2 29.11 
38 Ala 7.85 119.1 179.95 54.25 20.36 
39 Glu 8.56 114.7 176.79 55.98 30.5 
40 Phe 8.24 118.57 173.14 54.72 40.65 
41 Pro - - - 65.38 31.2 
42 Ser 8.27 115.58 175.68 60.45 62.68 
43 Leu 8.12 122.99 177.61 55.53 41.33 
44 Leu 7.51 121.06 178.42 56.91 41.76 
45 Lys 7.94 121.53 177.21 57.53 32.22 
46 Gly 7.99 109.72 - 45.44 - 
47 Met - - - - - 
48 Asn - - 176.26 55.51 37.96 
49 Thr 7.73 113.48 175.38 62.52 69.66 
50 Leu 7.67 123.99 177.85 58.61 42.12 
51 Asp 8.31 119.75 178.74 58.65 40.27 
52 Asp 7.92 121.83 178.93 57.35 40.51 
53 Leu 7.96 122.98 178.6 57.58 42.83 
54 Phe 8.96 121.35 176.68 62.73 39.79 
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Table 5.7.2 continued 
 
Residue 
No. Type 
1HN 15N 13C’ 13Cα 13Cβ 
55 Gln 7.7 116.73 177.87 58.68 28.63 
56 Glu 7.41 119.17 177.76 58.62 29.9 
57 Leu 7.47 119.63 177.27 55.51 42.81 
58 Asp 7.66 119.53 178.54 52.44 39.49 
59 Lys 8.06 127.37 177.69 59.05 32.02 
60 Asn 7.81 114.22 176.59 51.89 36.73 
61 Gly 7.7 110.21 174.41 47.78 - 
62 Asp 8.29 119.72 177.26 52.99 40.8 
63 Gly 10.57 115.26 173.99 45.93 - 
64 Glu 7.99 120.49 175.43 54.45 33.45 
65 Val 9.5 119.84 175.08 59.14 35.62 
66 Ser 8.5 118.08 175.4 56.48 66.5 
67 Phe 9.34 123.88 177.1 61.26 38.4 
68 Glu 8.54 120.13 179.57 60.25 29.07 
69 Glu 7.16 121.55 178.14 58.95 29.54 
70 Phe 8.69 122.41 175.64 60.71 39.51 
71 Gln 8.22 119.4 178.3 59.95 29.43 
72 Val 6.96 121.18 177.34 66.48 31.43 
73 Leu 7.83 123.9 178.3 59.95 41.84 
74 Val 8.02 118.08 178.19 66.42 31.21 
75 Lys 7.33 122.89 179.08 59.65 32.02 
76 Lys 8.12 120.24 179.76 59.38 32.74 
77 Ile 8.13 117.67 176.59 63.78 38.12 
78 Ser 7.51 116.82 174.17 59.88 63.83 
79 Gln 7.52 122.15 175.03 56.02 28.99 
80 Cys 7.61 125.62 178.62 60.22 29.08 
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Fig 5.7.5 
 15N-HSQC showing the backbone resonance assignment of the Ca2+ 
bound human calbindin D9k (P47M+C80). 
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Table 5.7.3 
 Backbone resonance assignment of the Ca2+bound human calbindin 
D9k(P47M+C80) in vitro at 37°C 
 
Residue 
No. Type 
1HN 15N 13C’ 13Cα 13Cβ 
1 Met - - - - - 
2 Ser - - - - - 
3 Thr - - - - - 
4 Lys - - 176.37 56.56 33.14 
5 Lys 8.35 124.13 175.92 55.27 34.55 
6 Ser 8.79 121.49 173.22 56.61 63.25 
7 Pro - - 179.51 66.17 31.92 
8 Glu 8.64 119.46 179.16 60.19 29.13 
9 Glu 7.85 123.21 179.44 59.13 30.15 
10 Leu 8.44 121.41 178.64 58.3 42.14 
11 Lys 8.07 121.99 177.59 59.94 32.26 
12 Arg 7.59 119.9 179.93 59.51 30.23 
13 Ile 8.18 121.94 176.74 65.88 38.75 
14 Phe 8.39 122.1 176.54 63.05 39.66 
15 Glu 8.48 117.56 179.18 59.14 29.92 
16 Lys 7.69 120.91 178.01 58.96 32.31 
17 Tyr 7.18 116.84 176.2 61.51 39.22 
18 Ala 8.3 121.21 178.98 54.23 17.76 
19 Ala 6.83 118.82 177.64 52.6 19 
20 Lys 7.16 122.1 177.23 60.33 32.75 
21 Glu 9.66 118.12 176.14 54.23 33.21 
22 Gly 8.87 114.91 173.99 46.06 - 
23 Asp 8.35 129.97 - 52.4 41.32 
24 Pro - - 174.49 64.23 31.46 
25 Asp 8.71 118.13 175.1 53.47 42.64 
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Table 5.7.3 continued 
 
Residue 
No. Type 
1HN 15N 13C’ 13Cα 13Cβ 
26 Gln 7.14 116.05 174.31 55.03 35.88 
27 Leu 9.5 127.49 176.63 53.21 44.44 
28 Ser 10.06 123.17 175.33 56.43 65.73 
29 Lys 8.65 123.56 178.22 61.27 31.17 
30 Asp 7.87 118.86 179.31 57.53 41 
31 Glu 7.74 122.22 178.79 59.53 30.69 
32 Leu 8.68 121.06 177.72 57.92 41.05 
33 Lys 8.12 121.04 177.71 60.71 32.04 
34 Leu 7.45 119.68 178.25 57.79 42.06 
35 Leu 7.82 123.47 179.04 58.89 42.58 
36 Ile 8.66 121.17 177.92 65.5 37.39 
37 Gln 8.19 117.56 177.15 59.39 28.83 
38 Ala 7.62 118.29 179.76 54.2 20.72 
39 Glu 8.13 114.48 176.75 56.22 30.96 
40 Phe 8.2 117.76 173.18 54.92 41.44 
41 Pro - - - 65.42 31.22 
42 Ser 8.31 116.37 - 60.66 62.55 
43 Leu 7.96 123.58 177.9 57.1 42.59 
44 Leu 7.4 117.95 176.8 54.69 41.24 
45 Lys 7.41 122.02 176.73 56.48 32.94 
46 Gly - - - - - 
47 Met - - - - - 
48 Asn - - 175.32 53.98 39.47 
49 Thr 8.09 113.6 175.24 61.53 71.22 
50 Leu - - 178.36 57.34 41.25 
51 Asp 8.08 120.11 178.54 58.26 40.54 
52 Asp 7.73 121.59 178.86 57.39 40.54 
53 Leu 8.01 123.9 178.16 57.65 42.08 
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Table 5.7.3 continued 
 
Residue 
No. Type 
1HN 15N 13C’ 13Cα 13Cβ 
54 Phe 8.82 121.08 176.29 63.47 39.73 
55 Gln 7.79 116.71 177.89 58.66 28.63 
56 Glu 7.62 120.34 178.1 58.66 29.62 
57 Leu 7.8 117.54 179.16 55.79 43.42 
58 Asp 7.84 119.49 177.09 52.98 38.21 
59 Lys 8.01 128.68 178.12 58.42 33.09 
60 Asn 7.92 114.15 176.35 51.93 37.03 
61 Gly 7.53 110.96 174.84 47.77 - 
62 Asp 8.16 120.7 177.62 53.22 40.54 
63 Gly 10.39 114.99 172.83 46.02 - 
64 Glu 7.73 120.21 175.97 54.01 34.71 
65 Val 10.26 128.3 175.62 61.4 33.43 
66 Ser 9.45 128.41 175.12 57.36 66.28 
67 Phe 9.54 124.98 177.66 61.98 38.17 
68 Glu 8.33 120.11 180.37 59.92 29.42 
69 Glu 7.88 123.08 179.53 58.92 29.88 
70 Phe 8.84 121.63 175.96 60.18 40.23 
71 Gln 7.54 117.38 177.53 58.09 27.87 
72 Val 7.08 119.68 177.86 65.82 31.98 
73 Leu 7.12 122.4 177.8 57.17 41.34 
74 Val 6.93 118.37 177.8 66.27 31.29 
75 Lys 7.43 120.62 178.32 58.95 32.23 
76 Lys 7.37 119.7 178.68 58.64 33.02 
77 Ile 7.61 117.17 176.91 62.92 38.3 
78 Ser 7.74 117.64 - 59.64 63.83 
79 Gln 7.72 122.23 174.99 55.95 29.32 
80 Cys 7.69 125.62 178.6 60 29.2 
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5.8 Lysine-selectively 15N-labelling of human calbindin 
D9k(P47M+C80). 
 
Lysine selectively 15N-labelling of human calbindin D9kwas 
performed for the reduction of ambiguity in the assignment transfer process 
for the in-cell NMR experiments (chapter 7.3). As there are 11 lysine 
residues in the human calbindin D9k(P47M+C80), it became easy to 
transfer the assignment from the uniformly 15N-labelled "assigned" spectra 
to the lysine-selectively labelled spectra. Selectively labelled spectra were 
assigned for the metal free, Mg2+ bound, and Ca2+ bound of human 
calbindin D9k(P47M+C80). The spectra of uniformly labelled and 
selectively labelled calbindin D9k(P47M+C80) in the metal free state were 
properly superimposed in order to confirmed their positions for metal free 
(fig 5.8.1). Likewise, the assignments were successfully transferred to the 
2D 1H-15N HSQC spectra of lysine-selectively 15N-labelled samples in the 
Mg2+ bound (Fig 5.8.2) and Ca2+bound (Fig 5.8.3) forms, respectively. 
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Fig. 5.8.1 
 Superimposed 15N-HSQC spectra of uniformly labelled (black) and 
lysine-selectively labelled (red) calbindin D9k (P47M+C80) in the 
metal-free state. 
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Fig. 5.8.2 
 Superimposed 15N-HSQC spectra of uniformly labelled (black) and 
lysine-selectively labelled (red) human calbindin D9k (P47M+C80) in the 
Mg2+-bound state. 
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Fig. 5.8.3 
 Superimposed 15N-HSQC spectra of uniformly labelled (black) and 
lysine-selectively labelled (red) human calbindin D9k (P47M+C80) in the 
Ca2+-bound state. 
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5.9 Homology modelling 
 
Homology modelling is a comparative modelling of protein, to 
construct an atomic-resolution model of the "target" protein from its amino 
acid sequence by using an experimentally determined three-dimensional 
structure of a related homologous protein as a template protein. Homology 
modelling relies on the identification of one or more known protein 
structures likely to resemble the structure of the query sequence, and on the 
production of an alignment of sequence that maps residues in the query 
sequence to residues in the template sequence. Evolutionarily related 
proteins have similar sequences and naturally occurring homologous 
proteins have similar protein structures. It has been shown that 
three-dimensional protein structures are evolutionarily more conserved than 
would be expected on the basis of sequence conservation alone [79], while 
the sequences falling below a 20% sequence identity can have very 
different structure [80]. Homology models can also be used to identify 
subtle differences between related proteins that have not all been solved 
structurally. 
As the human calbindin D9k structure was not solved yet, I used a 
program called “MODELLER” version 9.12 to generate the structure of 
human calbindin D9k, using bovine calbindin D9k (PDBID: 1CLB) as 
template. 
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From the backbone assignment, the chemical shift perturbation for 
the backbone 1HN and 15N nuclei of metal free calbindin D9k(P47M+C80) 
upon Ca2+ and Mg2+ binding were calculated and shown in Fig. 5.9.2. 
 
 
 
 
Fig 5.9.1 
 The structures was generated by homology modelling on a template 
structure of metal free Bovine calbindin (PDBID:1CLB) with the program 
MODELLER version 9.12. 
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Fig. 5.9.2. 
 Chemical shift perturbation for backbone 1HN and 15N nuclei of 
metal free calbindin D9k(P47M+C80) upon the calcium (a,d) and 
magnesium bound form (b,e), and of calcium bound calbindin 
D9k(P47M+C80) upon the magnesium bound form (c,f). The mean shift 
difference, δshift, for each amino acid residue was calculated as 
[(δ1HN)2+(δ15N)2]1/2, where δ1HN andδ15N are the chemical shift differences 
(Hz) for HN and 15N resonances observed at 14.1T (1H frequency is 600 
MHz). The colour coding on the ribbon diagrams is as follows: white (no 
assignment); light blue (0<δshift≤75 Hz); light green (75<δshift≤150 Hz); 
yellow (150<δshift≤300 Hz); orange (300<δshift≤600 Hz); red (δshift>600 Hz). 
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The arrows show the metal binding sites. The structures were calculated by 
homology modelling on a template structure of metal free Bovine calbindin 
(PDBID:1CLB) with the program MODELLER version 9.12. Molecular 
graphics images were produced using the program PYMOL version 1.3. 
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Chapter 6 
 
 
In-cell NMR Study in HeLa Cells 
 
 
6.1 Sample preparation for in-cell NMR experiments. 
 
 As discussed in the chapter 3, for in-cell NMR methods for HeLa 
cells, human calbindin D9k was prepared (discussed in chapter 5). The 
buffer of purified human calbindin D9k was changed to PBS (phosphate 
buffer saline), confirming no reducing agent is present in the buffer. The 
CPP sequence of Tat protein from HIV-1 (CPP-Tat: 
47-YGRKKRRQRRR-57) having an additional cysteine at its N-terminal 
was conjugated to the cysteine residue at carboxyl terminus of human 
calbindin D9k(P47M+80C), followed by a purification by using PD10 
column (GE Healthcare ). SDS-PAGE (loading buffer must be free from 
reducing agent like DTT) confirms the conjugation of human calbindin D9k 
with CPP-TAT. The purified human calbindin D9k-Cys-Cys-CPP-TAT was 
incubated (approximately 10 minutes) with HeLa cells (sub-cultures on a 9 
cm diameter petri dish, and are sticky to the plate) in the presence of 
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pyrenbutyrate (1-pyrenebutyric acid), which mediates the direct 
translocation of CPP-linked human calbindin D9k into the cytosol of the 
HeLa cells. This incubation process was repeated four times with an 
interval of 40 minutes. The incubation process was done in a humidified 
CO2 incubator at 37OC in Dulbecco’s Modified Eagle Medium (DMEM) 
buffer with 10% fatal bovine serum (FBS) and 1% penicillin-streptomycin, 
hence abbreviated as DMEM(+). Waiting for approx. 40 minutes after the 
final incubation, the HeLa cells were treated with Trypsin/EDTA in order to 
remove the cells from the dish plate. The cells were transferred to a 50 mL 
falcon tube containing freshly prepared medium containing DMEM(+) with 
HEPES (5mM) and D-glucose (90 mM), and then centrifuged at 2 G for 5 
minutes in room temperature and this process was repeated once more. 
Removing the supernatant by aspiration, the cells were re-suspended with 
100 µL of final in-cell NMR buffer which contains DMEM buffer, 5 mM of 
HEPES, 90 mM D-glucose and 10% D2O, and transferred to a 3mm 
Shigemi tube. The falcon tube was washed with 100 µL of NMR buffer 
again to collect the remaining cells and transferred to the same NMR tube. 
This loading process of cells onto the NMR tube leads to two different zone 
where the lower part of the NMR tube will be having highly densed cells 
and the upper part will be less. During the NMR measurement time all the 
cells will be precipitated at the bottom of the NMR tube and only buffer 
will be above the cells. This process doesn't affect the NMR measurement 
but the physiological property of the protein may change and could lead to 
observe different chemical shift on the NMR spectra.  
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Fig.6.1.1 
 A schematic drawing of an in-cell NMR sample in an NMR tube 
after loading the cells creates two zones. The lower part is higher cell 
density than the upper part. 
 
 
 
6.2 In-cell NMR measurement 
 
We performed the in-cell experiments by measuring a series of 2D 
1H-15N-SOFAST (band-Selective Optimized-Flip Angle Short Transient) 
HMQC spectra, which were measured in combination with a non-linearly 
sampling scheme in its indirect 15N-dimension. 
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Fig. 6.2.1 
 1H-15N-SOFAST-HMQC NMR experiment. Filled and open pulse 
symbols indicate 90° and 180° rf pulses, except for the first 1H excitation 
pulse applied with flip angleα. The variable flip-angle has a polychromatic 
PC9 shape and band-selective 1H re-focusing pulse is by REBURP [81]. 
Quadrature detection in   is obtained by phase incrementation of 
φaccording to TPPI-STATES.  Adiabatic WURST-2 decoupling is applied 
on 15N during detection.   
 
 
These methods were used to acquire the spectra in a short time due 
to short living time of HeLa cells in NMR tube. All the NMR 
measurements were performed at 37°C on a Bruker AVANCE III 600 MHz 
NMR spectrometer equipped with a cryogenic H/C/N probehead. The 
spectra were processed with MaxEnt method by Azara software version 
2.8. 
  
74 
 
Chapter 7 
 
 
Results and discussions  
 
 
7.1  1H-15N SOFAST-HMQC spectra of human 
calbindin D9k(P47M+C80) in HeLa cells. 
 
 15N-labelled calbindin D9k(P47M+C80) in the Ca2+-bound state was 
efficiently incorporated into HeLa cells with the help of C-terminal 
conjugated CPPTAT. Fig.7.1.1 shows a schematic diagram of the in-cell 
NMR experiments of calbindin D9k(P47M+C80) in HeLa cells. The 
concentration of calbindin D9k(P47M+C80) in an in-cell NMR sample was 
roughly estimated to be ~100 µM.  Fig 7.1.2-a show a 2D 1H-15N 
SOFAST-HMQC spectrum of uniformly 15N-labelled calbindin 
D9k(P47M+C80) in HeLa cells. The 1H-15N correlation cross peaks were 
well-resolved, suggesting that the proteins in side HeLa cells are properly 
folded.  
 
 
75 
 
7.1.1 Confirmation of in-cell sample, protein leakage and 
cell viability 
 
It is necessary to be confirmed that the proteins observed in the 
spectra were indeed inside the living cells. Hence after the in-cell NMR 
measurements the cells were taken out and centrifuged at 1000 rpm. The 
supernatant was removed and the precipitated cells were preserved for 
further investigations. The supernatant was centrifuged at 13000 rpm for 
complete precipitation of remained cells, and the soluble fraction was used 
for NMR measurements. Almost all 1H-15N correlation cross peaks 
disappeared in the spectrum recorded from supernatant (fig 7.1.2–b), 
confirming that the NMR signals were indeed from the proteins inside the 
cells. The preserved cells were lysed and the lysate was check by 
measuring NMR spectra. The essentially identical spectrum (Fig.7.1.2-c), 
with the exception of shaper line shape, was observed. These results 
demonstrated that the contribution of extracellular proteins to the observed 
signals is negligible. The viability of the HeLa cells after approximately 3.5 
hours of NMR measurements was confirmed to be 90±3 % by trypan-blue 
staining. 
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Fig 7.1.1 
 Schematic illustration of the in-cell NMR experiments of calbindin 
D9k(P47M+C80) in HeLa cells. 
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Fig 7.1.2 
 (a) a well spread 2D 1H-15N HSQC spectrum of human calbindin 
D9k(P47M+C80) inside HeLa cells, (b) a spectrum of the supernatant after 
the in-cell NMR experiments, (c) a spectrum of the lysate of the cells.  
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7.2 Resonance assignments of 1H-15N correlation cross 
peaks of human calbindin D9k(P47M+C80) in HeLa 
cells.  
 
When comparing the sequential spectra (each took 38 minutes) in 
time-dependent changes in the cross peak pattern were apparently noticed 
(Fig.7.2.1). We repeated the in-cell NMR experiments employing the 
identical experimental parameters, and found that these changes were 
highly reproducible.  
In order to investigate these changes in detail, the 1H-15N correlation cross 
peaks in each in-cell NMR spectrum were analysed in reference to the in 
vitro assignments of calbindin D9k(P47M+C80) in the metal free, Mg2+- 
and Ca2+-bound states. However, considering the overlap of cross peaks in 
the in-cell NMR spectra, which is mainly caused by the line broadening 
due to increased viscosity in the cytosol and specific/nonspecific 
interactions with various intracellular factors, we anticipated difficulties in 
the assignment transfer process from the in vitro to the in-cell NMR data: 
solid assignments for isolated peaks, whilst highly ambiguous assignments 
for overlapped or significantly broadened peaks.  
 For the assignment transfer process, in-cell spectra were 
corroborated with in vitro resonance assignments for human calbindin 
D9k(P47M+C80), ( See chapter ) 
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Fig 7.2.1 
 Time course of the 2D 1H-15N SOFAST-HMQC spectra of 
uniformly 15N-labelled calbindin D9k(P47M+C80) in HeLa cells. The 
spectra were obtained during the period of 0 to 38 minutes (a), 39 to 76 
minutes (b), 77 to 114 minutes (c), 115 to 152 minutes (d), and 153 to 190 
minutes (e) from the start of the in-cell NMR experiments. 
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7.3 Lysine-selectively 15N-labelling of human calbindin 
D9k (P47M+C80) and in-cell NMR measurements 
 
 As it became difficult to assign and for clear understanding in 
in-cell NMR measurement, it became necessary to reduce the cross peak in 
the spectra by selective labelling of the human calbindin D9k and followed 
by in-cell NMR measurement. 
 Lysine-selectively 15N-labelled calbindin D9k(P47M+C80) was 
prepared and incorporated into HeLa cells for in-cell NMR experiments, 
for simplifying the spectra, and further assignment transfer process, thus 
enabling to provide more accurate assignments. Fig.7.3.1 Shows a series of 
2D 1H-15N SOFAST-HMQC spectra of lysine-selectively 15N-labelled 
calbindin D9k(P47M+C80) in HeLa cells. All the NMR experiment 
parameters are kept same as the experiments on the uniformly 15N-labelled 
in-cell NMR samples in order to avoid ambiguity.  
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Fig. 7.3.1 
 Time course of the 2D 1H-15N SOFAST-HMQC spectra of 
lysine-selectively 15N-labelled calbindin D9k(P47M+C80) in HeLa cells. 
The spectra were obtained during the period of 0 to 38 minutes (a), 39 to 
76 minutes (b), 77 to 114 minutes (c), 115 to 152 minutes (d), and 153 to 
190 minutes (e) from the start of the in-cell NMR experiments. 
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7.4 Time-dependent conversion of calbindin 
D9k(P47M+C80) from the Mg2+- to the 
Ca2+-bound states inside HeLa cells. 
 
 Fig 7.2.1 shows the time course of the 1H-15N SOFAST-HMQC 
spectra of the uniformly 15N-labelled human calbindin D9k (P47M+C80) 
inside HeLa cells. Fig 7.3.1 shows the similar time course of the 1H-15N 
SOFAST-HMQC spectra of the lysine-selectively 15N-labelled calbindin 
D9k(P47M+C80) inside HeLa cells. As calbindin D9k binds various metals it 
can be hypothesised that this type of change in spectra could be related to 
its metal- binding (or binding to some other intracellular components).  
Therefore, the spectra were first compared with the 1H-15N HSQC spectrum 
of the sample in the Ca2+-bound state in vitro. 
 From the fig: 7.4.1 it is inferred that in the initial stage of the in-cell 
NMR measurement (0-38 min), the number of observed 1H-15N correlation 
cross peaks were less than expected, but the cross peak pattern has good 
agreement with that of the Mg2+-bound state in in vitro. 
 In contrast, the cross peaks observed on uniformly and 
lysine-selectively [Fig.7.4.2 (a) and (b) respectively] 15N-labelled calbindin 
D9k(P47M+C80) in HeLa cells in the later stages (114-152 min from the 
start of the experiments) showed almost identical chemical shifts with the 
corresponding cross peaks of the in vitro Ca2+-bound calbindin 
D9k(P47M+C80).  
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Fig 7.4.1 
 Overlay of the 2D 1H-15N SOFAST-HMQC spectra of calbindin 
D9k(P47M+C80) in HeLa cells (black) and the 2D 1H-15N HSQC spectra of 
calbindin D9k(P47M+C80) in vitro (red). In the panel a, the spectrum of 
uniformly 15N-labelled calbindin D9k(P47M+C80) in HeLa cells which 
were obtained during the periods of 0 to 38 minutes from the start of the 
in-cell NMR experiments was compared with uniformly 15N-labelled 
calbindin D9k(P47M+C80) in the Mg2+-bound state in vitro. Likewise, in 
panel b, the spectrum of lysine-selectively 15N-labelled calbindin 
D9k(P47M+C80) in HeLa cells which were obtained during the periods of 0 
to 38 minutes from the start of the in-cell NMR experiments was compared 
with lysine-selectively 15N-labelled calbindin D9k(P47M+C80) in the 
Mg2+-bound states in vitro. For each panel, cross-peaks in the in-cell NMR 
spectra are labelled with their corresponding backbone assignments. 
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Fig 7.4.1 continued 
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Fig 7.4.2 
 Overlay of the 2D 1H-15N SOFAST-HMQC spectra of calbindin 
D9k(P47M+C80) in HeLa cells (black) and the 2D 1H-15N HSQC spectra of 
calbindin D9k(P47M+C80) in vitro (red). In the panel a, the spectrum of 
uniformly 15N-labelled calbindin D9k(P47M+C80) in HeLa cells which 
were obtained during the periods of 114-152 minutes from the start of the 
in-cell NMR experiments was compared with uniformly 15N-labelled 
calbindin D9k(P47M+C80) in the Ca2+-bound state in vitro. Likewise, in 
panel b, the spectrum of lysine-selectively 15N-labelled calbindin 
D9k(P47M+C80) in HeLa cells which were obtained during the periods of 
114-152 minutes from the start of the in-cell NMR experiments was 
compared with lysine-selectively 15N-labelled calbindin D9k(P47M+C80) in 
the Ca2+-bound states in vitro. For each panel, cross-peaks in the in-cell 
NMR spectra are labelled with their corresponding backbone assignments. 
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Fig 7.4.2 continued 
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Fig.7.4.3 
 Time course of the 2D 1H-15N SOFAST-HMQC spectra of 
uniformly 15N-labelled calbindin D9k(P47M+C80) in HeLa cells. In upper 
panel, the metal-free proteins were used for the incorporation process into 
HeLa cells. In lower panel, corresponding spectra for which Ca2+-bound 
calbindin D9k(P47M+C80) was used were shown for comparison. The 
spectra were obtained during the period of 0 to 38 minutes, 39 to 76 
minutes, 77 to 114 minutes and 115 to 152 minutes, respectively from the 
start of the in-cell NMR experiments. 
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 First, these results demonstrated that the Ca2+ ions which were 
initially bound to the CPPTAT-conjugated calbindin D9k(P47M+C80) were 
somehow released during the incorporation process into HeLa cells. This 
was confirmed by the similar in-cell NMR experiments employing the 
metal-free calbindin D9k(P47M+C80) for the incorporation process, in 
which identical results were obtained (Fig.7.4.3). 
 Further our results showed that the calbindin D9k(P47M+C80) just 
after the incorporation process binds Mg2+ ions. Time-dependence in signal 
intensity of representative cross-peaks suggested that the conversion from 
Mg2+- to Ca2+-bound states occurred continuously (Fig. 7.4.4). 
 
 
 
 
Fig.7.4.4 
 1D cross sections of 2D 1H-15N SOFAST-HMQC spectra of 
lysine-selectively 15N-labelled calbindin D9k(P47M+C80) taken at the 
positions corresponding to the K75 residue in the Mg2+- (left panel) and 
Ca2+-bound state (right panel), indicating the time-dependent change in 
cross-peak intensity. Inverted triangles indicate the positions of the amide 
proton resonances due to the K75 residue. 
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To interpret the results, we hypothesised that the Ca2+-burst , 
presumably from Endoplasmic Reticulum (ER) happened continuously 
after the start of the in-cell NMR experiments, consequently the bound 
Mg2+ ions were replaced by Ca2+ ions, since the affinity of calbindin D9k to 
Ca2+ is approximately 103-fold higher than Mg2+. In order to investigate 
when this Ca2+-burst and the resulting time-dependent changes in calbindin 
D9k(P47M+C80) start during the experiments, we introduced extra 
incubation time (3 hours) in DMEM(+) on the culture dish between the 
protein incorporation and the NMR sample preparation processes for in-cell 
measurement in the protocol (Fig. 7.4.5).  
The additional incubation time caused no significant difference in 
in-cell NMR spectra (Fig7.4.6), demonstrating that the time-dependent 
changes in the spectra do not start after the incorporation of calbindin 
D9k(P47M+C80), but initiated after the NMR sample preparation process, 
in which HeLa cells were removed from the culture dish by trypsin/EDTA, 
washed and placed into an NMR tube. 
 As was mentioned above Ca2+-burst occurs in HeLa cells under 
various stresses. It is known that NMR radio frequency pulses, which 
continuously move and reorient ions and polar molecules by the alternating 
electric field, thereby increasing the sample temperature. In order to verify 
the possibility that the RF pulses, and the resulting local temperature 
increase in HeLa cells, contribute the increase of cytosolic Ca2+ 
concentration, we therefore modified the protocol and left in-cell NMR 
samples inside the magnet for 2 hours without applying any RF pulses 
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before starting NMR measurements (Fig. 7.4.7-a). 
 
 
 
 
 
 
Fig.7.4.5 
 Schematic illustration of the in-cell NMR experiments of calbindin 
D9k(P47M+C80) in HeLa cells with additional 140 minutes incubation on 
culture plates. 
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Fig.7.4.6 
 Time course of the 2D 1H-15N SOFAST-HMQC spectra of 
uniformly 15N-labelled calbindin D9k(P47M+C80) in HeLa cells obtained 
by employing the modified protocol shown in Fig.7.4.5. The spectra were 
acquired during the period of 0 to 38 minutes (a), 39 to 76 minutes (b), 77 
to 114 minutes (c), and 115 to 152 minutes (d) from the start of the in-cell 
NMR experiments.  
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Fig.7.4.7 
 a. Schematic illustration of the in-cell NMR experiments of 
calbindin D9k(P47M+C80) in HeLa cells with additional 120 minutes 
incubation in NMR tube inside magnet. b. The 2D 1H-15N 
SOFAST-HMQC spectrum of uniformly 15N-labelled calbindin 
D9k(P47M+C80) in HeLa cells obtained by employing the modified 
protocol shown in panel a. 
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 The 1H-15N SOFAST-HMQC spectrum measured after this 
additional incubation time in the magnet showed essentially identical cross 
peak pattern (Fig.7.4.7-b) to that of the Ca2+-bound state, suggesting that 
the NMR RF pulses is not the major cause for the increase of cytosolic Ca2+ 
concentration. 
 We have established a method and successfully monitor the increase 
of cytosolic Ca2+ concentration in HeLa cells by observing the 
time-dependent changes in the 2D 1H-15N correlation cross peaks of 
calbindin D9k(P47M+C80), which was incorporated into the cells. The 
spectra from the metal free calboindin D9k (P47M+C80) incorporated in to 
HeLa cells and the spectra from the Ca2+-bound are similar, hence 
confirming that the metal bound to the protein released during the 
incorporation process. Though it is hard to predict properly, but the initial 
spectrum matches the Mg2+ bound in vitro spectrum, showing a clear 
indication that the protein is initially in the Mg2+-bound state inside the 
HeLa cells. Then it was revealed that continuous increase of cytosolic Ca2+ 
concentration, which is detected as the time-dependent change in the in-cell 
NMR spectra of calbindin D9k(P47M+C80) from the Mg2+- to Ca2+-bound 
states, is autonomously induced as responses to various stresses caused by 
removing cells from the culture dish by trypsin/EDTA and packed into an 
NMR tube, and the subsequently happened cell precipitation due to gravity, 
the starvation of oxygen and nutrient contents etc (Fig. 7.4.8). The RF 
pulses applied to HeLa cells during the NMR experiments are proved not to 
be the major source of this process.  
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Fig.7.4.8 
 In normal cells (a) in order to maintain the Ca2+ level in cytosol, the 
Ca2+ are pumped into the ER or sometimes to mitochondria. The cells in 
stressed conditions (b), the ER releases Ca2+ to cytosol. 
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Chapter 8 
 
 
Conclusion and Future prospects 
 
 
8.1. Conclusion 
 
I have optimised the protocol for the in-cell NMR method in HeLa 
cells and Ca2+ binding process inside the HeLa cells.  
Optimisation for the incorporation of human calbindin D9k into 
HeLa cells was successfully done. It was also optimised that the CPPTAT 
bound target protein undergo conformational changes during membrane 
transportation as we have noticed that the Ca2+ was released during 
incorporation process. This incorporation process may not be a good idea 
for proteins with metal-binding activities. 
Inside NMR tube, the HeLa cells were eventually stressed, and 
hence Ca2+ was released from ER, which was absorbed by calbindin D9k 
protein. Though proteins' interaction with metals or other substrates inside 
cells have been studied by other biophysical methods, to the best of our 
knowledge, the results presented in this thesis are the first demonstration by 
in-cell NMR method, detecting cellular functions like releasing of Ca2+ due 
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to stress and further binding of these Ca2+ to the target protein inside cells 
in NMR time scale. These kinds of experiments can be tested with the 
cellular functions of various target protein under stressed condition inside 
cells. In this context, our method will provide a very useful tool for in situ 
monitoring of the "healthiness" of the cells in various in-cell NMR studies. 
 
 
8.2. Future Prospects 
 
Protein structure determination and its interaction with its partner 
molecule inside prokaryotic cells has been tested, and extending to 
mammalian cells is the next to be investigated. Short measurement time in 
terms of NMR pulse sequence like SOFAST, non-linear sampling 
techniques, etc. need to be optimized to acquire a quality NMR spectra in 
short time. 
As was mentioned above one of the major limitations of the in-cell 
NMR experiments is the short life time of cells during the NMR 
measurements, and improvements of NMR apparatus, aiming at keeping 
cells alive by e.g. recycling the media during NMR measurement82, have 
been reported. In the future, in-cell NMR studies in mammalian cells may 
head in the direction of achieving more "physiological" condition during 
the experiments.  
The other challenge is its inherent low sensitivity, making relatively 
high concentrations of the observed macromolecules necessary. In 
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particular, in-cell NMR investigations that focus on the observation of the 
behaviour of a particular protein in its natural environment are affected by 
this disadvantage.  Most proteins occur in the cellular environment at 
the low µM to nM level. Interaction studies of an overexpressed protein 
that reached mM concentrations in the bacteria or mammalian cells with its 
natural interaction partners is, therefore, not exactly the physiological 
condition hence in most cases the current sensitivity of NMR spectrometers 
or methods in NMR spectrometer need to be enhanced.  
In the method developing stage of mammalian in-cell NMR, the 
goals are to observe protein behaviours while cells are "alive" during the 
experiments and the physical and chemical properties of the targeted 
macromolecules. It is true that the cells have higher degree of selectivity 
for producing such biological macromolecule and they are not inert inside 
cells and having proper functions or dysfunction (leads to diseases). 
Keeping this type of scenario, in-cell NMR methods need to be carried out. 
Once these approaches are getting matured, more detailed information 
about the biological molecules inside cells and the condition of host cells, 
together called cellular structural biology can be investigated by in-cell 
NMR spectroscopy. 
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